Equity Analysis

Quarterly Results

    Bliss GVS Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    506197
    INE416D01022
    97.2888746
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    BLISSGVS
    15.72
    1271.52
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.68
    1
    0.41
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales182.65148.96163.82
Other Operating Income0.000.000.00
Other Income 8.356.848.46
Total Income191.00155.80172.28
Total Expenditure 157.27122.22179.75
PBIDT33.7333.58-7.47
Interest 3.451.171.53
PBDT30.2932.41-9.00
Depreciation6.396.266.23
Tax8.747.035.99
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.90-0.29-9.76
Reported Profit After Tax17.0419.42-11.46
Extra-ordinary Items 0.000.00-35.10
Adjusted Profit After Extra-ordinary item17.0419.4223.64
EPS (Unit Curr.)1.631.85-1.11
EPS (Adj) (Unit Curr.)1.631.85-1.11
Calculated EPS (Unit Curr.)1.621.85-1.09
Calculated EPS (Adj) (Unit Curr.)1.621.85-1.09
Calculated EPS (Ann.) (Unit Curr.)6.487.41-4.38
Calculated EPS (Adj) (Ann.) (Unit Curr.)6.487.41-4.38
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.5110.4910.47
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)18.4722.54-4.56
PBDTM(%)16.5821.76-5.49
PATM(%)9.3313.04-7.00
Dividend Per Share(Rs)0.000.000.00
Diluted EPS1.631.81-1.08